SCHEMBL7320665

SCHEMBL7320665

COC(=O)c1cnn(-c2ccc(C=O)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
HPGDS O60760 1/20 0.45
ALKBH2 Q6NS38 1/20 0.45
MAPT P10636 7/20 0.44
RAB9A P51151 6/20 0.44
KDM4E B2RXH2 5/20 0.44
NPC1 O15118 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
MAPKAPK2 P49137 1/20 0.43
KCNJ1 P48048 1/20 0.43
MAPK1 P28482 2/20 0.42
HPGD P15428 2/20 0.41
HTT P42858 2/20 0.40
GAA P10253 1/20 0.40
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NFKB1 P19838 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325573 0.84 CA12 (0.53) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL7322694 0.82 MAPKAPK2 (0.48) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL30872607 0.82 ALKBH2 (0.68) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL8085746 0.82 HPGDS (0.68) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL7323051 0.80 HPGDS (0.45) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL7320411 0.79 ALDH1A1 (0.49) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL7326021 0.78 ALDH1A1 (0.48) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL7321749 0.78 CA12 (0.52) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL27166306 0.76 NPC1 (0.48) ALDH1A1HPGDSALKBH2MAPTRAB9A
SCHEMBL15153223 0.75 ATM (0.46) ALDH1A1HPGDSALKBH2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715904-A CDK2 degrading agents and uses thereof 凯麦拉医疗公司 2024-03-15 CN disclosed
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed
US-6232290-B1 FUNGICIDES AGAINST PNEUMOCYSTIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-15 US disclosed
EP-1053247-A1 ANTIFUNGAL CYCLOHEXAPEPTIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-22 EP disclosed
WO-1999040108-A1 NEW COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-08-12 WO disclosed